Ally Bridge Group »

Compass Pathways shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Compass Pathways (CMPS) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Compass Pathways

Tip: Access up to 7 years of quarterly data

All positions including Compass Pathways held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Pathways by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $12M 2.2M 5.73
2025-06-30 $4.2M 1.5M 2.80

More positions owned by Ally Bridge Group

Soleno Therapeutics (SLNO)
Replimune Group Call Option (REPL)
Madrigal Pharmaceuticals (MDGL)
Compass Pathways Sponsored Ads (CMPS)
Atai Beckley Nv SHS (ATAI)
Ascendis Pharma A/s - Sponsored Adr (ASND)
Lenz Therapeutics (LENZ)
Taysha Gene Therapies Com Shs (TSHA)
Amylyx Pharmaceuticals (AMLX)
Eupraxia Pharmaceuticals (EPRX)
Praxis Precision Medicines I Com New Call Option (PRAX)
Monopar Therapeutics Com New (MNPR)
Arcutis Biotherapeutics (ARQT)
Mind Medicine Mindmed Com New (MNMD)
Tarsus Pharmaceuticals (TARS)

View all positions for Ally Bridge Group

Top funds holding Compass Pathways

Rtw Investments
Deep Track Capital
GMT Capital Corp
Millennium Management
Tang Capital Management
Ally Bridge Group
UBS Group
ARK Investment Management
Nantahala Capital Management
Partner Fund Management
Leucadia National Corporation
Hsbc Holdings
Ameriprise Financial
Aisling Capital Management
Susquehanna International

View all funds holding Compass Pathways